Back to Endocrinology
Endocrinologyv2001Evidence-Based

FINDRISC (Finnish Diabetes Risk Score)

Identifies patients at high risk for type 2 diabetes within 10 years without the need for laboratory tests

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
risk score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The FINDRISC (Finnish Diabetes Risk Score) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within endocrinology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum of points based on: Age (0-4 points) + BMI (0-3 points) + Waist circumference (0-4 points) + Physical activity (0-2 points) + Fruit/vegetable consumption (0-1 point) + Blood pressure medication (0-2 points) + High blood glucose history (0-5 points) + Family diabetes history (0-5 points)

Clinical Pearls & Practice Notes

  • First degree relatives include parents, siblings, or children
  • Second degree relatives include grandparents, aunts, uncles, or cousins
  • Waist circumference thresholds differ by gender: Men (normal <94cm, elevated 94-102cm, high ≥102cm); Women (normal <80cm, elevated 80-88cm, high ≥88cm)
  • No laboratory tests required for this assessment

Evidence & Literature Citations

  1. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003 Mar;26(3):725-31. doi: 10.2337/diacare.26.3.725.
  2. Saaristo T, Peltonen M, Lindström J, Saarikoski L, Sundvall J, Eriksson JG, et al. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res. 2005 May;2(2):67-72. doi: 10.3132/dvdr.2005.011.
  3. Tankova T, Chakarova N, Atanassova I, Dakovska L. Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. Diabetes Res Clin Pract. 2011 Apr;92(1):46-52. doi: 10.1016/j.diabres.2010.12.020.

Score Interpretation Ranges

Very Low0 – 3 pts

Very low risk

Low4 – 8 pts

Low risk

Moderate9 – 12 pts

Moderate risk

High13 – 20 pts

High risk

Very High21 – 26 pts

Very high risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.